Farmitalia Carlo Erba S.r.l.

Pharmacia & Upjohn S.p.a.

Italfarmaco Spa

Marco Adami

Roberto Magrini

Antonino Suarato

Paolo Mascagni

Luciano Gambini

Roberta Artico

Tiziano Oldoni

Daniele Barbareschi

Jaime Moscoso

Paolo Maranghi

Rosaria Mariani

Rosanna Dalla Casa

Giovanni Perrone

Physically and chemically stable aqueous oral suspensions of riluzole and manufacturing methods thereof. The suspensions contain riluzole in particle form and at least a wetting agent, preferably a surfactant. Riluzole is present in amounts from about 0.1% to about 20% w/v and has an average particle size lower than 200 &#x3bc;m. The suspensions are devoid of the known local (mouth) anaesthetic effects of riluzole.

Riluzole aqueous suspensions

A lyophilized composition comprising (a) a conjugate comprising a N-alkyl methacrylamide-based copolymer and an anthracycline glycoside linked through a peptide spacer to the copolymer and (b) a cosolubilizing agent may optionally also contain (c) a filler. Also optionally, a targeting moiety may be linked to the copolymer of the conjugate via a peptide spacer. An injectable solution of the conjugate is obtained by reconstitution of the lyophilized composition.

Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation

A stable lyophilized formulation of a fibroblast growth factor (FGF) comprises the FGF, a pharmaceutically acceptable bulking agent and either

Stable pharmaceutical compositions containing a fibroblast growth factor

Growing community of inventors

Milan, Italy

Marco Adami